EIT's Cellular Titanium Receives FDA Approval

Emerging Implant Technologies' (EIT) 3D printed Cellular Titanium spinal implants have been used in more than 10,000 cases in over 15 countries, including Germany, France, Korea, Australia and the Netherlands. Now, the FDA has granted 510(k) approval to the technology, meaning that EIT, which is based in Germany, can begin the full commercialization process in the United States. Learn more about these implants at 3DPrint.com: http://3dprint.com/181640/eit-3d-pri...ular-titanium/

http://3dprint.com/wp-content/upload...d-1024x440.jpg